#United States #Alzheimer's #Neurodegeneration #Silvi Foundation #Fairless Hills

The Silvi Foundation Launches with a Mission to Combat Neurodegenerative Diseases

On February 26, 2026, the Silvi Foundation proudly announced its official launch as a nonprofit organization. This initiative aims to drive forward essential research on neurodegenerative diseases, primarily focusing on Alzheimer’s, dementia, ALS, and similar conditions. The foundation's first significant step involves a generous grant of $100,000 awarded to the Institute for Neurodegenerative Diseases (IND), dedicated to pioneering research on blood-based biomarkers that could transform early detection and diagnosis of these debilitating ailments.

The foundation was established in tribute to Larry Silvi Sr., a respected entrepreneur and founder of Silvi Materials, alongside his wife Rose, both of whom faced the challenges posed by Alzheimer’s disease. Their personal journey underscores the Silvi family's enduring dedication to scientific advancements in combatting neurodegenerative disorders.

Joy Silvi, the President of the Silvi Foundation, shared her family’s vision: “The launch of the Silvi Foundation indicates a heartfelt commitment from our family. We have personally witnessed the profound impact that neurodegenerative diseases exert on both patients and their caregivers. Our mission is to allocate resources towards thorough research and groundbreaking strategies that can expedite discovery and enhance outcomes for families affected.”

The initial funding to IND focuses on developing practical, blood-based diagnostic tools aimed at determining neurodegenerative disease risks before any overt symptoms arise. Such innovation holds the potential to fortify clinical research efforts, optimize treatment planning, and significantly elevate patient care.

IND’s ongoing research targets biomarkers that might reveal disease progression indicators across Alzheimer's disease, Parkinson's disease, Lewy Body Dementia, and Frontotemporal Dementia. The support from the Silvi Foundation is intended to cover essential laboratory equipment, research personnel costs, biorepository development, and ongoing biomarker assessments.

Through strategic grantmaking and partnerships with leading research institutions, the Silvi Foundation aspires to create momentum toward earlier diagnoses and more effective treatment methodologies for individuals and families grappling with neurodegenerative diseases. This groundwork builds upon the foundation’s commitment to responsible philanthropy and a profound care for the community.

For additional insights about the Silvi Foundation or to contribute to its mission, individuals can visit the foundation's official site at silvifoundation.org.

About the Silvi Foundation

The Silvi Foundation collaborates with top-tier research entities and organizations aligned with its mission to enhance understanding, early diagnosis, treatment, and overall care for those impacted by neurodegenerative conditions. Guided by personal narratives and a profound commitment to philanthropy, the foundation champions initiatives that bear significant scientific relevance and promise.

About Silvi Materials

Founded by Larry Silvi Sr., Silvi Materials stands as a premier supplier of construction materials, including ready-mix concrete, cement, stone, sand, and more, with a strong presence across Pennsylvania, New Jersey, and North Carolina. The company remains family-owned, driven by principles of long-term perspective, accountability, and dedication to service.